Activated platelets may present a hyperactive phenotype following C5a-C5aR1 activation, a phenomenon that has been observed for other diseases such as COVID-19 (Apostolidis et al. 2022; Caillon et al. 2022). The gene discussed is C5AR1; the disease is COVID-19.